Evidence map›Paper›PMID 35074352›Full record

ArticleEnvironmental research2022

Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach.

Albert Carcereny, David Garcia-Pedemonte, Adán Martínez-Velázquez, Josep Quer, Damir Garcia-Cehic, Josep Gregori, Andrés Antón, Cristina Andrés, Tomàs Pumarola, Carme Chacón-Villanueva and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Environmental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Dynamics of SARS-CoV-2 variants in southwest Ohio municipal wastewater.Environmental science : water research & technology · 2025
    Article
  4. Article
  5. Detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) in wastewater samples: a wake-up call, Finland, Germany, Poland, Spain, the United Kingdom, 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Albert CarcerenyEnteric Virus Laboratory, Section of Microbiology, Virology and Biotechnology, Department of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona Diagonal 643, 08028, Barcelona, Spain; Enteric Virus Laboratory, Institute of Nutrition and Food Safety (INSA), University of Barcelona, Spain.
David Garcia-PedemonteEnteric Virus Laboratory, Section of Microbiology, Virology and Biotechnology, Department of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona Diagonal 643, 08028, Barcelona, Spain; Enteric Virus Laboratory, Institute of Nutrition and Food Safety (INSA), University of Barcelona, Spain.
Adán Martínez-VelázquezEnteric Virus Laboratory, Section of Microbiology, Virology and Biotechnology, Department of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona Diagonal 643, 08028, Barcelona, Spain; Enteric Virus Laboratory, Institute of Nutrition and Food Safety (INSA), University of Barcelona, Spain.
Josep QuerLiver Unit, Liver Diseases - Viral Hepatitis, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Campus, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Damir Garcia-CehicLiver Unit, Liver Diseases - Viral Hepatitis, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Campus, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Josep GregoriLiver Unit, Liver Diseases - Viral Hepatitis, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Campus, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Andrés AntónMicrobiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Campus, Barcelona, Spain.
Cristina AndrésMicrobiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Campus, Barcelona, Spain.
Tomàs PumarolaMicrobiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Campus, Barcelona, Spain.
Carme Chacón-VillanuevaPublic Health Office, Health Departament, Generalitat de Catalunya, Spain.
Carles M BorregoCatalan Institute for Water Research (ICRA), Girona, Spain; Group of Molecular Microbial Ecology, Institute of Aquatic Ecology, University of Girona, Spain.
Albert BoschEnteric Virus Laboratory, Section of Microbiology, Virology and Biotechnology, Department of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona Diagonal 643, 08028, Barcelona, Spain; Enteric Virus Laboratory, Institute of Nutrition and Food Safety (INSA), University of Barcelona, Spain. Electronic address: abosch@ub.edu.
Susana GuixEnteric Virus Laboratory, Section of Microbiology, Virology and Biotechnology, Department of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona Diagonal 643, 08028, Barcelona, Spain; Enteric Virus Laboratory, Institute of Nutrition and Food Safety (INSA), University of Barcelona, Spain. Electronic address: susanaguix@ub.edu.
Rosa M PintóEnteric Virus Laboratory, Section of Microbiology, Virology and Biotechnology, Department of Genetics, Microbiology and Statistics, School of Biology, University of Barcelona Diagonal 643, 08028, Barcelona, Spain; Enteric Virus Laboratory, Institute of Nutrition and Food Safety (INSA), University of Barcelona, Spain. Electronic address: rpinto@ub.edu.
Universitat de Barcelona · ESInstituto de Salud Carlos III · ESVall d'Hebron Institut de Recerca · ESGeneralitat de Catalunya · ESUniversitat de Girona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wastewater based epidemiology (WBE) offers an overview of the SARS-CoV-2 variants circulating among the population thereby serving as a proper surveillance method. The variant of concern (VOC) Alpha was first identified in September 2020 in the United Kingdom, and rapidly became dominant across Europe. Our objective was to elucidate the Alpha VOC outcompetition rate and identify mutations in the spike glycoprotein (S) gene, indicative of the circulation of the Alpha VOC and/or other variants in the population through wastewater analysis. In the period covered by this study (November 2020-April 2021), forteen wastewater treatment plants (WWTPs) were weekly sampled. The total number of SARS-CoV-2 genome copies per L (GC/L) was determined with a Real-Time qPCR, targeting the N gene. Surveillance of the Alpha VOC circulation was ascertained using a duplex RT-qPCR, targeting and discriminating the S gene. Our results showed that in a period of 6 weeks the Alpha VOC was present in all the studied WWTPs, and became dominant in 11 weeks on average. The outcompetition rates of the Alpha VOC were estimated, and their relationship with different parameters statistically analyzed. The rapid spread of the Alpha VOC was influenced by its initial input and by the previous circulation of SARS-COV-2 in the population. This latter point could be explained by its higher transmissibility, particularly advantadgeous when a certain degree of herd immunity exists. Moreover, the presence of signature mutations of SARS-COV-2 variants were established by deep-sequencing of the complete S gene. The circulation of the Alpha VOC in the area under study was confirmed, and additionally two combinations of mutations in the S glycoprotein (T73A and D253N, and S477N and A522S) that could affect antibody binding were identified.

Indexed as

COVID-19SARS-CoV-2HumansWastewaterWastewater-Based Epidemiological MonitoringWastewaterAlpha VOCNGSOutcompetition rateVariant of concernWastewater-based epidemiology

Identifiers

PMID35074352
PMCPMC8782736
OpenAlexW4207045356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.